Why Egalet Shares Are Plummeting After FDA Approval Of ARYMO ER

After initially spiking as much as 20 percent on Monday following FDA approval of ARYMO ER, shares of Egalet Corp EGLT 0.75% are down more than 16.4 percent in early Tuesday trading. For traders wondering why Egalet shares are selling off after such good news, the devil is in the details.

Opioid Abuse And Abuse-Deterrent Properties

Opioid abuse has become a major problem in the United States in recent years, and the FDA has begun placing heavy emphasis on abuse-deterrent options to the drugs that are already on the market. Egalet was hoping to gain an abuse-deterrent label from the FDA for ARYMO ER; The drug was approved with an abuse-deterrent label for intravenous delivery.

The FDA was clear that ARYMO ER is approved for “the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.” In other words, doctors should prescribe ARYMO ER as a last resort after all other treatment options are exhausted.

That’s certainly not what Egalet and its shareholders were hoping for from the FDA and does very little to differentiate ARYMO ER from the other opioids already on the market. It’s…

Click here to continue reading

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!